Kyongbo Pharmaceutical
Asan, South Korea
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Kyongbo Pharmaceutical
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Asan, South Korea
- Website
- https://www.kbpharma.co.kr/en/
- Modalities
- Small Molecule API, Cytotoxics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Kyongbo Pharmaceutical
Kyongbo Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Cytotoxics. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.kbpharma.co.kr/en/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Frequently Asked Questions About Kyongbo Pharmaceutical
Does Kyongbo Pharmaceutical have a CDMO Signal Score?
Not yet. Kyongbo Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Kyongbo Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Kyongbo Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Fermion
Espoo, Finland
Small Molecule API, High-Potency APIs, Cytotoxics, Oral Solid Dose, Sterile Injectables, Semi-solids & Liquids
Sichuan Qingmu Pharmaceutical
Meishan, Sichuan, China
Small Molecule API, High-Potency APIs, Cytotoxics, Oligonucleotide
Nippon Kayaku
Takasaki, Gunma, Japan
High-Potency APIs, Cytotoxics, Small Molecule API, Microbial Fermentation
CKD BiO
Ansan, South Korea
Microbial Fermentation, Small Molecule API, Intermediates
Samyang Biopharm
Seoul, South Korea
Sterile Injectables, Cytotoxics, Lyophilization, Oncology Products
Compare Kyongbo Pharmaceutical with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.